# Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-ii-randomized-trial-of-rituximab-plus-cyclophosphamide-followed-by/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yemil Atisha‐Fregoso,Susan Malkiel,Kristina M. Harris,M. Byron,Linna Ding,Sai Kanaparthi,William T. Barry,Wendy Gao,Kristin Ryker,Patti Tosta,Anca Askanase,Susan A. Boackle,W. Winn Chatham,Diane L. Kamen,David R. Karp,Kyriakos A. Kirou,S. Sam Lim,Bradley Marder,Maureen McMahon,Samir V. Parikh,William F. Pendergraft,Amber S. Podoll,Amit Saxena,David Wofsy,Betty Diamond,Dawn E. Smilek,Cynthia Aranow,Maria Dall’Era |
| Citations | 212 |
| DOI | 10.1002/art.41466 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1002/art.41466 |
| OpenAlex ID | https://openalex.org/W3047551100 |
| PMID | 32755035 |
| Type | article |
| Year | 2020 |

## Paper authors

- [David R. Karp](https://scholariq.org/researchers/david-r-karp/)
- [Cynthia Aranow](https://scholariq.org/researchers/cynthia-aranow/)
- [Maria Dall’Era](https://scholariq.org/researchers/maria-dall-era/)

## Paper journal

- [Arthritis & Rheumatology](https://scholariq.org/journals/arthritis-and-rheumatology/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.